SIC
MRVI icon

SJS Investment Consulting’s Maravai LifeSciences MRVI Stock Holding History

SJS Investment Consulting’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.43K Buy
+390
New +$1.68K ﹤0.01% 1693
2024
Q4 		– Sell
-2
Closed -$17 – 1669
2024
Q3 		$17 Hold
2
– – ﹤0.01% 1644
2024
Q2 		$15 Sell
2
-2
-50% -$17 ﹤0.01% 1650
2024
Q1 		$35 Hold
4
– – ﹤0.01% 1622
2023
Q4 		$27 Buy
4
+1
+33% +$6 ﹤0.01% 1606
2023
Q3 		$30 Sell
3
-2
-40% -$22 ﹤0.01% 1612
2023
Q2 		$63 Sell
5
-1
-17% -$13 ﹤0.01% 1547
2023
Q1 		$85 Buy
6
+3
+100% +$43 ﹤0.01% 1477
2022
Q4 		$43 Buy
3
+2
+200% +$31 ﹤0.01% 1548
2022
Q3 		$0 Buy
+1
New +$25 ﹤0.01% 1349

Other funds holding MRVI

DRP
Decker Retirement Planning Levi, Utah $294M AUM 97.44% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM

SJS Investment Consulting's MRVI Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 390 shares worth $2.43K. The stake represents ﹤0.01% of the portfolio and ranks #1693 among its holdings. This is a return to the name: SJS Investment Consulting previously reported a position in MRVI as recently as Q3 2024.

SJS Investment Consulting first reported a position in MRVI in Q3 2022 and has held it in 10 quarters since. 7 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • SJS Investment Consulting held 390 shares of Maravai LifeSciences worth $2.43K as of Q2 2026.
  • Maravai LifeSciences was a new SJS Investment Consulting position in Q2 2026.
  • Maravai LifeSciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1693 holding.
  • SJS Investment Consulting first reported a position in Maravai LifeSciences in Q3 2022 and has held it in 10 quarters since.
  • 7 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.